We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bladder Cells Use Exocytosis to Fight Urinary Tract Infections

By LabMedica International staff writers
Posted on 02 Aug 2016
A team of molecular microbiologists has identified a method used by the cells lining the bladder to protect themselves against urinary tract pathogens by packaging bacteria into vesicles that are expelled from the cytoplasm. More...


Investigators at Duke University (Durham, NC, USA) and colleagues at the National University of Singapore (Singapore) worked with mice and cultured human bladder cells to study the mechanism used by the bladder to fight off urinary tract infection (UTI).

They reported in the July 19, 2016, online edition of the journal Immunity that infected bladder epithelial cells (BECs) mobilized the exocyst complex, a powerful exporter of subcellular vesicles, to rapidly expel intracellular bacteria back for clearance. In this process, called exocytosis, membrane-bound secretory vesicles are carried to the cell membrane, and their contents (water-soluble molecules such as proteins) are secreted into the extracellular environment. This secretion is possible because the vesicle transiently fuses with the outer cell membrane.

While the investigators had previously reported that expulsion of harmful bacteria was partially mediated by lysosomes, cellular structures that ordinarily degrade waste, this was the first report of bacterial expulsion via exocytosis. In addition, this process was linked to action of the compound Forskolin, which has a strong impact on urinary tract infections, even in the absence of antibiotics. Forskolin activates the enzyme adenylyl cyclase and increases intracellular levels of cAMP, an important second messenger necessary for the proper biological response of cells to hormones and other extracellular signals.

"There is growing interest in identifying new ways to fight UTIs, as bacteria are becoming increasingly resistant to antibiotics," said senior author Dr. Soman Abraham, professor of pathology, immunology, microbiology, and molecular genetics at Duke University. "In the past, we identified a plant extract called Forskolin, which has a strong impact on UTIs, even in the absence of antibiotics. Unfortunately, we did not understand how it worked. These latest findings could provide the key to how the herb effectively combats UTIs. If this link can be established, we could help advance the case for testing the herb and other similar-acting drugs as a potential new treatment for UTIs."

Related Links:
Duke University
National University of Singapore

New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.